© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Butaphosphan started to grab attention back in the mid-twentieth century. Livestock farming demanded tools to boost animal metabolism and deal with stress-related downturns in productivity. German chemists and veterinarians led the early research, searching for organophosphorus compounds that could supply easily absorbable phosphorus. Early results caught on fast within veterinary practice across Europe. Producers noticed that adding this compound to their toolkit helped animals handle periods of high performance and critical life stages. Over the decades, firms in animal health tweaked formulations and improved dosages. Regulations around phosphonate use in animal health grew stricter, pushing manufacturers to deliver more transparent data. Backed by a steady trickle of clinical studies, butaphosphan’s adoption spread beyond Europe and started appearing in North American and Asian markets as producers tackled the same set of challenges.
Veterinary injectable solutions containing butaphosphan often show up in sturdy glass vials, usually teamed with other actives like cyanocobalamin. Labels usually pitch the product as a metabolic stimulant for cattle, swine, horses, or even companion animals like dogs and cats. Feedlot managers turn to butaphosphan blends during stress periods or following calving, lambing, or farrowing. The logic stays simple: animals with low phosphorus struggle to maintain feed intake, milk yield, or optimal growth. Injectable forms bypass the digestive roadblocks—something oral phosphorus often can’t manage, especially when illness knocks an animal off feed. Given how tightly the animal health field regulates injections, production chains stick to Good Manufacturing Practices and batch traceability.
Chemically, butaphosphan belongs to the phosphonic acid ester family. It appears as a clear colorless liquid, easily soluble in water. Storage runs trouble-free at moderate temperatures, since the compound resists oxidation and degradation under normal barn conditions. The chemical formula, C7H20O2P, lays out the carbon and phosphorus backbone. Butaphosphan stands out for stability—it does not degrade quickly or break down into hazardous byproducts within the bottle’s expiration date or at body temperature. This means ranchers face fewer headaches with storage and handling. In lab tests, its purity consistently hits high marks, almost always coming in above 98%.
Labeling keeps things direct—concentration of butaphosphan per milliliter, recommended dosages, warnings for withdrawal periods, and explicit handling directions. Most injectable products package at 100 mg/mL, sometimes paired with B12 at 50 mcg/mL. Stated uses cover metabolic disorders, stress support, and recovery from illness or heavy labor. Labels warn against using in animals meant for immediate slaughter unless a withdrawal period clears. Veterinary guidance always shows up in bold type, a sign of how tightly controlled and critical proper dosing remains for livestock health.
Manufacturers synthesize butaphosphan by reacting phosphorus trichloride with suitable alcohols in the presence of base, then run purification with water and solvents to yield pharmaceutical-grade injectables. Quality control analysts take samples from each batch, running spectral analysis and chromatography to confirm identity and purity. Preparing injectable butaphosphan involves rigorous sterilization—a contaminated batch could spark losses for producers and possible regulatory blowback. Firms usually keep the preparation process confidential but still report key method outlines to regulators as part of safety filings.
Butaphosphan holds its ground in most common pH ranges. It doesn’t react quickly with feed ingredients or injectable companions. Odd reactions with strong acids or oxidizers remain rare in farm environments due to proper storage. Some researchers have probed ester modifications, seeking longer-acting forms or various salts, but mainstream products still favor the original form for injectables. Laboratory tests often run through hydrolysis and breakdown studies, confirming the stability profile under stress so that product spoilage in the field remains a non-issue.
Butaphosphan pops up under various spellings, especially in European and Asian markets. Among the most recognized alternate names, one finds butafosfan, butafosphanum, and phosphoric acid tributyl ester. Trademarked products such as Catosal, ButaPhos, or PhytonTrex dominate catalogue listings. These brand choices often shift based on local regulatory approvals and market strategy. Regulatory filings always trace back to the same core compound, regardless of the private label or regional spelling.
Animal health workers face a strict checklist around safety when handling butaphosphan. Wearing gloves and protective glasses keeps accidental splashes out of contact points. Spill response scripts stay ready on feedlots and veterinary practices, where even minor exposure calls for rapid clean-up and disposal focused on environmental responsibility. Firms selling butaphosphan stick to international quality standards: ISO certifications, GMP protocols, and routine audits. Producers shipping into the EU or North America need clear documentation regarding residue limits, purity control, and environmental benchmarks. Practitioners in the field learn proper injection sites and volumes to spare animals unnecessary tissue trauma or local reactions.
Livestock managers lean on butaphosphan for its effect on metabolism during calving, weaning, lactation, and other stress-intensive periods. Dairy herds see fewer cases of post-partum downer cows when supplementing with phosphorus, especially after tough births or poor feed intake. Breeding operations inject sows to aid farrowing recovery. Horses regain pep after grueling work or travel by tapping into these phosphorus reserves. In practice, butaphosphan supports veterinarians in situations where classic feeding won’t do—injectable phosphorus kicks in fast and helps animals bounce back before the rest of the herd feels the impact.
Research on butaphosphan runs deeper today than in its early years. Peer-reviewed studies tackle performance outcomes, such as daily weight gains in beef cattle, milk production spikes in dairy cows, or post-transport recovery in swine. Some teams look at the compound’s role in calf immunity and disease resistance, with initial data pointing to improved energy handling and reduced disease severity. Advances in analytical chemistry let drug makers spot impurities at the molecular level, which has made new product development safer and more reliable. Competition between brands encourages tweaks in formulation, such as combining with trace elements or vitamins tailored to modern feed deficiencies.
Long-term safety stays central to butaphosphan’s continued use. Toxicity studies in rodents and livestock show a wide safety margin when dosing remains within veterinary guidelines. Overdosing rarely causes acute harm, since excess phosphorus clears through regular metabolic pathways, but chronic overuse leads to problems with mineral balance and secondary symptoms like poor kidney function. Veterinary case records and post-market surveillance grab adverse event data, shaping label changes over time. Regulatory agencies demand ongoing monitoring, especially as global residue testing tightens in export markets.
Butaphosphan’s future looks tied to shifts in animal nutrition, precision agriculture, and consumer demand for transparency. Farmers search for ways to fine-tune inputs, satisfy animal welfare groups, and still hit efficiency goals. Point-of-care diagnostics may soon help veterinarians target phosphorus supplementation with even more precision, scaling back blanket injections and lowering costs. Ongoing studies look at links between phosphorus metabolism, immune resilience, and climate resilience, hinting at broader roles for organophosphorus compounds. Global expansion likely hinges on countries updating feed additive rules and embracing smarter animal monitoring tech. Industry stewards keep watch for resistance or residues that could affect food safety or trade. The job for the next decade likely involves balancing rapid advances in livestock tech with the nuts-and-bolts requirements of running a safe, responsible, and productive operation.
Anyone who’s worked closely with livestock knows stress often hits animals hard, sometimes much harder than people imagine. Calving, weaning, transport, rapid weather changes—each can send cows, pigs, or goats into a metabolic tailspin. Farmers and veterinarians need real options when animals start fading under the load. That’s where butaphosphan enters the conversation. This compound, usually given by injection, supports animals grappling with acute or chronic stress, helping keep their heads above water.
Butaphosphan blends with vitamin B12 as a team. Their partnership makes sense. Butaphosphan contains phosphorus, a mineral working behind the scenes in nearly every cell—energy production, muscle movement, and nerve signaling rely on it. In ruminants, especially, phosphorus quickly drops during times of stress or metabolic demand. Cows calving or suffering from ketosis typically need all the help they can get.
I've watched tired cows bounce back after calving when treated with butaphosphan and B12. Producers often notice better appetite, brighter eyes, even a willingness to move that wasn’t there the day before. Field studies back this up—one German trial found dairy cows treated at calving returned to eating and milking faster than untreated herdmates. These animals produced more milk during the first critical weeks. It isn’t just about numbers on a spreadsheet; it’s the difference between a cow thriving or sliding into deeper trouble.
Sheep and goats get similar benefits. Cases of pregnancy toxemia—where ewes run out of blood sugar before lambing—present real problems. Producers lose animals every year to this condition. The butaphosphan-B12 combo offers a practical, rapid-acting boost. In pigs, especially newborns and sows under stress, this supplement also gets regular use.
Many animal advocates push for solutions that reduce pain and suffering, and for good reason. Livestock work is about more than profit; it’s about stewardship. Every time a farmer can intervene early and help a struggling animal stand on its own, food security and animal dignity both take a step forward. This respect for living things underpins the principles of animal welfare embraced by veterinarians and responsible producers.
Butaphosphan shouldn’t serve as a crutch for sloppy nutrition or hygiene. If a herd lacks proper minerals day-to-day, no injection will fix that foundation. Experience says: review the ration, check mineral feeders, and keep animals housed clean and comfortable. Good management builds the foundation, so butaphosphan and B12 make the biggest impact in truly tough moments.
Some critics question over-reliance on pharmaceuticals in animal production, fearing drug residues or creating a false sense of security. That worry has real footing. Responsible veterinarians always look at the bigger picture, weighing benefits with possible downsides. At its heart, butaphosphan offers one valuable tool—especially for farmers facing unpredictable weather, industrial scale herds, and intense production cycles.
Research continues into exactly how butaphosphan works at the molecular level and which animals benefit the most. Veterinarians remain the best source for recommendations. For my part, watching a down cow rise after treatment sticks with you. Solutions like butaphosphan are neither a luxury nor a shortcut; they’re another way to respect animals and keep food chains running, often when problems hit hardest.
Butaphosphan shows up as a phosphorus-based veterinary drug, mostly used alongside cyanocobalamin (vitamin B12) to help animals bounce back from metabolic stress. Dairy and beef producers sometimes count on it when cows drop weight after calving or drop their appetite during stress. In day-to-day practice, vets may lean on Butaphosphan injections to perk up weak animals, especially after difficult births.
Research on Butaphosphan’s effect during pregnancy or lactation doesn’t fill many books. The European Medicines Agency, among others, notes that safety in pregnant or lactating animals hasn’t been fully proven. Most available studies focus on general performance in healthy, adult livestock. So far, direct evidence showing harm or confirming absolute safety in pregnant cows, goats, or sheep is missing.
I’ve talked to veterinarians who see fast improvement after using Butaphosphan in worn-out cows, but even they admit they stay careful with pregnant animals. A 2015 study in the veterinary journal "Animals" looked at Butaphosphan and B12 in fresh cows and saw benefits in energy balance but didn’t follow the calves closely or track birth outcomes. Pregnancy and newborns always mean higher stakes, so the lack of long-term hard data makes even seasoned experts think twice before reaching for this drug in a pregnant cow’s worst hour.
Every medicine can steer the body in ways nobody expects. Phosphorus itself helps build bones and keep energy moving, but shifting these balances during pregnancy risks causing trouble you might not spot right away. A mother’s liver and kidneys work overtime, and pushing extra drugs could stress a system that’s already running close to redline. With lactating animals, there’s the added problem of drug residues slipping into milk, which stirs up worries for food safety and milk quality.
Mature cows and goats have handled Butaphosphan without big problems in published trials, though these trials often skip pregnant or freshly calved animals, so they don’t answer the real question. In my experience, most farmers rely on tried-and-true methods — balanced feed, good bedding, low stress — before adding any injections during pregnancy. At calving time, the mother’s ups and downs already feel like a high-wire act, and it’s easy to see why nobody wants to add another risky variable, no matter how promising the drug sounds on paper.
Regulators and veterinarians agree that playing it safe makes sense here. They push for large, transparent field studies. Weighing the practical risks and benefits works best when everyone — producers, vets, and researchers — sees results in the real world instead of just in a lab. Until then, producers stick with current best practices and reach for Butaphosphan only if there’s nothing else on the table and under close vet supervision.
This issue carries extra weight because a single misstep with mother or calf can ripple down a whole year’s work on the farm. There’s no shortcut around careful, evidence-backed vet advice before choosing any supplement or drug for pregnant or lactating animals. With a little more honest field research, both animal health and food safety could get the clarity they deserve.
Any time an animal shows signs of stress—whether from calving, transport, illness, or heavy workload—farmers and veterinarians look for supportive therapy tools. Butaphosphan, paired often with vitamin B12, finds a place on many farms and clinics for this reason. It backs up metabolism and boosts recovery, or at least that’s the intent. I’ve spent enough time around cattlemen, equine vets, and small animal people to notice: each group treats dosing a little differently.
In practice, cattle usually get butaphosphan dosed at around 0.1 to 0.25 milliliters per kilogram of body weight per injection. A mature dairy cow, for example, weighing about 600 kilograms, takes roughly 60 to 150 milliliters per treatment, usually as a subcutaneous or intramuscular shot. Folks generally split the dose if it gets too big, so the animal doesn’t end up with a big lump under the hide. For calves, the volume drops in step with their weight—often 5 to 10 milliliters works for a young animal. Most vets suggest repeating the dose every 24 hours for two or three days, especially after calving or during transport stress. This keeps the blood phosphorus up during recovery.
Pigs aren’t just smaller—growth and recovery jump quickly with metabolic support. Butaphosphan dosing for sows lands around 5 to 10 milliliters per head, often before or after farrowing and during times of feed change. For piglets, most guidelines point to 1 to 3 milliliters per animal. Giving the injection subcutaneously helps with absorption, and care gets taken to avoid nerves in the neck. Swine folks check for cluster fatigue in sows, then make dosing a tool for getting better litter productivity. It’s straightforward enough that commercial swine units keep the product close by, especially on larger operations.
Horses demand an approach that fits their muscle mass, metabolic swings, and stress sensitivity. Most equine vets use 5 to 20 milliliters per adult, usually repeat dosing once a day for up to five days, depending on the condition. Hard-working horses—like eventers, racehorses, or horses coming off illness—show the biggest metabolic swings, so higher doses win out for a few days at a time. In foals or young horses under heavy stress, 2 to 5 milliliters offers support. Intramuscular is the main route, since intravenous can get risky. Safety matters with horses, and folks avoid using large doses in a single spot to keep muscle reaction down.
Vets treating dogs tend to use between 1 and 5 milliliters, matching the animal’s weight and the problem. Cats need less—maybe 0.5 to 2 milliliters. Subcutaneous or intramuscular injections both get used, but cats often protest if a cold solution comes their way. Practices rely on butaphosphan especially when treating metabolic or stress-induced conditions, or if a city dog faces sudden trauma, surgery, or disease. A repeat dose, after 24 hours, is common if the issue drags on.
I’ve heard stories of overenthusiastic use, especially by folks hoping for a quick fix. While butaphosphan is considered safe at recommended doses, going overboard can strain the kidneys and cause discomfort. Checking kidney and liver function in weak animals gives peace of mind before and during therapy. Sticking to proven dosages, logging every treatment, and training staff in safe injection technique protect the animal and the person on the other end of the needle.
Butaphosphan finds real traction on farms and in clinics because recovery is everything when animals get pushed or sick. Picking the right dose depends on the species, weight, and what the animal faces. Talk to a vet, use a sharp needle, and stay within safe dosing windows. That’s where this injectable can make the difference between a slow recovery and a rebound.
Butaphosphan ends up in many cattle barns and veterinary clinics, often dressed up in the form of metabolic boosters. This phosphorus-based compound shows up in products with a blend of vitamin B12. Many farmers and vets count on it, trying to support recovery from stress, illness, or tired muscles in farm animals. Its role stretches from speeding up recovery after calving to supporting weakened animals after transport or infection.
Every experienced cattleman or vet knows that no injectable comes risk-free. With butaphosphan, most animals deal with it pretty well. Still, every now and again, animals can show local swelling, soreness, or reddening at the injection spot. These local reactions usually fade in a day or two, but I’ve seen some animals get restless, especially if the shot was rushed or it landed in muscle instead of under the skin. In rare cases, cattle can become hypersensitive, showing signs that mimic common allergic responses—think labored breathing or sudden collapse right after injection. These cases remain uncommon, but every barn should keep emergency treatments nearby, just in case.
If butaphosphan is given at much higher doses than recommended, symptoms can kick in. Animals might seem excited, breathe a little faster, or lose their appetite for a day or two. Too much phosphate in the body can throw off natural balances, putting kidneys under strain—more so in animals already dealing with chronic illnesses or poor hydration. Bloodwork sometimes turns up high phosphorus or low calcium if someone pushes the dose well past what’s standard.
Giving butaphosphan to healthy animals for no reason doesn’t bring extra benefits. If an animal comes in already overloaded with phosphorus—for example, because of kidney failure, severe metabolic disease, or high-phosphorus rations—the risks outweigh any gains. High phosphorus can cause muscle weakness, trouble standing, or worse, especially if the patient struggles with kidney issues. I have seen dairy operations make the mistake of using these injectables without proper bloodwork, only to realize later that an animal had hidden kidney trouble.
No one should give butaphosphan to animals that ever had allergic reactions to the compound or to the other ingredients in the product. That includes preservatives or vitamin B12, depending on the brand and batch. Pregnant and lactating animals usually tolerate it, but there is no long-term research that tracks repeated dosing for months at a time, so using it without a concrete need in every cow or pig in the herd doesn’t make sense.
Making sure that animals really need butaphosphan before giving it remains the best way to avoid trouble. Bloodwork and physical exams should back up each decision. If local irritation shows up after an injection, switching to a new site next time or slowing down the injection can help. For herds with a habit of overusing metabolic boosters, regular continuing education goes a long way—both on farms and in clinics.
The best strategy always pairs careful dosing with solid animal monitoring after injection. If any animal reacts badly, have emergency drugs ready—think antihistamines or corticosteroids. Reporting rare or serious side effects to veterinary authorities helps keep the whole livestock community safer. In my experience, honest talk with clients and records of all injections build stronger trust, making side effects and rare complications easier to spot before they snowball.
Keeping butaphosphan effective starts before it ever reaches an animal. I’ve seen more than one veterinary clinic overlook storage, thinking the job is over once bottles sit on the shelf. The reality is, temperature and exposure mess with chemical stability. Butaphosphan belongs in a cool, dark spot, shielded from sunlight and away from heat sources. Direct rays from a window or sitting near a water heater? That can degrade it, cutting down on results when animals need support during stress or metabolic trouble.
The packaging says “store below 25°C” because temperatures above that speed up breakdown. Just last year, I spoke with a dairy consultant who found spoiled butaphosphan in a barn fridge after the cooling element failed. Paying attention here saves headaches later. Unopened bottles stay safest inside a dedicated medicine cabinet or veterinary fridge, not next to daily-use supplies that see the sun. Opened vials must go back in quickly, with the cap sealed tight to discourage contamination.
Giving butaphosphan isn’t just a matter of drawing a dose and injecting wherever there’s space. Every animal responds better when technique follows the recommendations. I remember my first days watching seasoned farm vets. They always used a fresh needle, checked the vial for particles, cleaned the injection spot, and made sure the animal was safely restrained. These steps sound simple, yet skipping any one of them can bring infection or reduce the benefit.
Dosage varies by species and reason for use, so following the label or a veterinarian’s direction matters. For most livestock, the injection goes under the skin or into muscle — never by mouth, not in feed, not just “wherever.” Putting the medicine into the wrong tissue can hurt the animal, or in some cases, make absorption unreliable. At livestock shows, I’ve seen people cut corners under time pressure, only to regret it after sick animals show up a few days later. Taking 30 seconds to get it right can protect animal health and farmer income.
I’ve witnessed cattle lose weight or fail to recover from illness because somebody left a bottle open or injected too close to bone. Spoiled product can’t deliver the phosphorus boost stressed animals rely on. Worse, contaminated vials can spread bacteria—turning a cure into a cause of disease.
It’s tempting, especially late at night during calving season, to skip label reading or reuse needles. Every instance increases the odds of a setback. Studies in Germany found that following proper storage and administration habits actually improved herd recovery rates after metabolic crises. That pays off directly at market and reduces antibiotic use from avoidable infections.
Everyone on a farm or in a clinic has a role to play. Posting basic guides in every medicine storage area can remind even the busiest workers. Investing in a dedicated lockable fridge, training staff, and tossing expired product keep things safe and simple. It costs less in the long run than dealing with a barn full of sick animals or a ruined show season. In my experience, habits built over years trump even the fanciest new treatments when emergencies roll in. Butaphosphan can do its job—but only if people treat it right every time.
| Names | |
| Preferred IUPAC name | [Butan-1-yl(dihydroxyphosphoryl)oxyphosphanyl]oxyphosphonic acid |
| Other names |
Butafosfan Butafosphan Buthafosfan |
| Pronunciation | /bjuːˈtæf.ɒsfæn/ |
| Identifiers | |
| CAS Number | 17316-67-5 |
| Beilstein Reference | 1523080 |
| ChEBI | CHEBI:31213 |
| ChEMBL | CHEMBL2105981 |
| ChemSpider | 80723 |
| DrugBank | DB11436 |
| ECHA InfoCard | 100.100.371 |
| EC Number | 210-836-7 |
| Gmelin Reference | 72932 |
| KEGG | C18116 |
| MeSH | D015046 |
| PubChem CID | 3034406 |
| RTECS number | WS6180000 |
| UNII | 99BH31ID4A |
| UN number | UN2902 |
| CompTox Dashboard (EPA) | DTXSID2023377 |
| Properties | |
| Chemical formula | C7H17O2PS |
| Molar mass | 322.27 g/mol |
| Appearance | Clear, colorless to slightly yellow solution |
| Odor | Odorless |
| Density | 1.175 g/cm³ |
| Solubility in water | Soluble |
| log P | 1.35 |
| Acidity (pKa) | 2.4 |
| Basicity (pKb) | 7.62 |
| Refractive index (nD) | 1.513 |
| Viscosity | Viscous liquid |
| Dipole moment | 4.01 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 560.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -4460 kJ/mol |
| Pharmacology | |
| ATC code | QA16QA91 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. Causes skin irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS05,GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | P264, P270, P273, P280, P301+P312, P305+P351+P338, P330, P501 |
| Lethal dose or concentration | LD50 (oral, rat): >2000 mg/kg |
| LD50 (median dose) | LD50 (median dose) for Butaphosphan: "more than 5,000 mg/kg (oral, rat) |
| NIOSH | Not listed |
| PEL (Permissible) | Not established |
| REL (Recommended) | 10 mg/kg |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Phosphothiamine Phosphorylated vitamins Cyanophosphan Phosphine oxide derivatives Vitamin B derivatives |
